TAMARACK ADVISERS, LP – Rigel Pharmaceuticals, Inc. Transaction History
TAMARACK ADVISERS, LP portfolio value:
$2.36M
portfolio value
TAMARACK ADVISERS, LP quarter portfolio value change:
+4.42%
quarter
Rigel Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 100K | $1.18 | 2M | |
| Q2 2022 | share | Decrease | -38.46% | -1.25M shares | -7.45M | $1.13 | 2M |
| Q1 2022 | share | Decrease | -27.78% | -1.25M shares | -2.20M | $2.99 | 3.25M |
| Q4 2021 | call | Decrease | -100.00% | -5K shares | -100K | $2.68 | 0 |
| Q4 2021 | share | Decrease | -35.71% | -2.5M shares | -13.48M | $2.68 | 4.5M |
| Q3 2021 | call | Increase | 0.00% | 5K shares | 100K | $3.63 | 5K |
| Q3 2021 | share | Increase | +9.38% | 600K shares | -2.36M | $3.63 | 7M |
| Q2 2021 | share | Decrease | -23.35% | -1.95M shares | -781K | $4.34 | 6.4M |
| Q1 2021 | share | Increase | +12.08% | 900K shares | 2.59M | $3.42 | 8.35M |
| Q4 2020 | share | Decrease | -0.67% | -50K shares | 7.96M | $3.5 | 7.45M |
| Q3 2020 | share | Increase | +9.49% | 650K shares | 5.46M | $2.4 | 7.5M |
| Q2 2020 | share | Increase | +23.42% | 1.3M shares | 3.87M | $1.83 | 6.85M |
| Q1 2020 | share | Decrease | -3.48% | -200K shares | -3.13M | $1.56 | 5.55M |
| Q4 2019 | share | Increase | +5.02% | 275K shares | 1.55M | $2.14 | 5.75M |
| Q3 2019 | share | 0.00% | 0 shares | -3.77M | $1.87 | 5.47M | |
| Q2 2019 | share | Increase | +3.30% | 175K shares | 395K | $2.61 | 5.47M |
| Q1 2019 | share | Decrease | -3.64% | -200K shares | 971K | $2.57 | 5.3M |
| Q4 2018 | share | Increase | +20.88% | 950K shares | -1.95M | $2.3 | 5.5M |
| Q3 2018 | share | Increase | +73.33% | 1.92M shares | 7.17M | $3.21 | 4.55M |
| Q2 2018 | share | Increase | 0.00% | 2.62M shares | 7.42M | $2.83 | 2.62M |